Biocept Inc logo

BIOC - Biocept Inc News Story

$4.43 -0.3  -6.9%

Last Trade - 3:43pm

Sector
Healthcare
Size
Micro Cap
Market Cap £45.4m
Enterprise Value £36.9m
Revenue £19.5m
Position in Universe 5460th / 6856

BRIEF-European Patent Granted For Biocept's Target Selector Oncogene Mutation Enrichment And Detection Platform

Tue 31st July, 2018 1:28pm
July 31 (Reuters) - Biocept Inc  BIOC.O :
    * EUROPEAN PATENT GRANTED FOR BIOCEPT'S TARGET SELECTOR
ONCOGENE
MUTATION ENRICHMENT AND DETECTION PLATFORM

Source text for Eikon:  ID:nPn22Wd3Wa 
Further company coverage:  BIOC.O 

 ((Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.